IGC Pharma, Inc.
IGCNYSECIK 1326205HealthcareFiscal year ends Dec 31
Reports and events: 271 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-09-0916:55 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-22-001082 |
| 2022-08-0517:20 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001185185-22-000890 |
| 2022-07-2508:47 ET | DEF 14A | Proxy statementPeriod 2022-09-09 | 0001185185-22-000846 |
| 2022-06-2317:50 ET | 10-K | Annual reportPeriod 2022-03-31 | 0001185185-22-000768 |
| 2022-06-0915:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-22-000734 |
| 2022-05-1216:49 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001185185-22-000608 |
| 2022-04-1817:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-22-000461 |
| 2022-03-2316:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001185185-22-000312 |
| 2022-02-1016:06 ET | 10-Q | Quarterly reportPeriod 2021-12-31 | 0001185185-22-000162 |
| 2022-01-1816:55 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001185185-22-000067 |
| 2021-12-0210:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-21-001785 |
| 2021-11-1917:17 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001185185-21-001711 |
| 2021-10-2916:20 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001185185-21-001552 |
| 2021-10-1516:46 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-21-001484 |
| 2021-09-1517:14 ET | DEF 14A | Proxy statementPeriod 2021-10-15 | 0001185185-21-001301 |
| 2021-08-1117:07 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001185185-21-001100 |
| 2021-06-1417:26 ET | 10-K | Annual reportPeriod 2021-03-31 | 0001185185-21-000802 |
| 2021-02-1617:58 ET | 10-Q | Quarterly reportPeriod 2020-12-31 | 0001185185-21-000201 |
| 2021-01-1417:48 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-21-000081 |
| 2021-01-1317:04 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001185185-21-000077 |
| 2020-12-2220:56 ET | 8-K | 8.01 Other events | 0001185185-20-001766 |
| 2020-12-0816:16 ET | DEF 14A | Proxy statementPeriod 2021-01-11 | 0001185185-20-001724 |
| 2020-11-2016:06 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001185185-20-001659 |
| 2020-08-2014:59 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-20-001222 |
| 2020-08-1916:06 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001185185-20-001220 |
| 2020-08-1117:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-20-001126 |
| 2020-07-2019:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-20-001030 |
| 2020-07-1320:00 ET | 10-K | Annual reportPeriod 2020-03-31 | 0001185185-20-000984 |
| 2020-05-1316:04 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-20-000623 |
| 2020-05-0821:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-20-000572 |
| 2020-03-2720:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-20-000356 |
| 2020-03-1618:35 ET | 8-K | 8.01 Other events | 0001185185-20-000298 |
| 2020-02-1016:06 ET | 10-Q | Quarterly reportPeriod 2019-12-31 | 0001185185-20-000150 |
| 2020-01-0916:05 ET | 8-K | 5.07 Shareholder vote results | 0001185185-20-000029 |
| 2019-12-1316:38 ET | DEF 14A | Proxy statementPeriod 2020-01-07 | 0001185185-19-001718 |
| 2019-11-0617:53 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001185185-19-001517 |
| 2019-08-0921:29 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001185185-19-001094 |
| 2019-06-1417:19 ET | 10-K | Annual reportPeriod 2019-03-31 | 0001185185-19-000890 |
| 2019-03-2721:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-19-000412 |
| 2019-02-2608:37 ET | 8-K | 8.01 Other events | 0001185185-19-000283 |
| 2019-02-2220:18 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-19-000269 |
| 2019-02-1917:04 ET | 8-K | 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001185185-19-000263 |
| 2019-02-1220:44 ET | 10-Q | Quarterly reportPeriod 2018-12-31 | 0001185185-19-000224 |
| 2018-11-1318:25 ET | 8-K | 3.01 Delisting notice; 8.01 Other events | 0001185185-18-001968 |
| 2018-11-0219:16 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001185185-18-001897 |
| 2018-10-1620:21 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001185185-18-001848 |
| 2018-10-1019:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-18-001826 |
| 2018-10-0117:15 ET | 8-K | 8.01 Other events | 0001185185-18-001782 |
| 2018-10-0106:09 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001185185-18-001776 |
| 2018-09-2408:04 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001185185-18-001745 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.